Cargando…
Clinical Outcomes of Ustekinumab in Inflammatory Bowel Disease
Inflammatory bowel diseases including Crohn's disease (CD) and ulcerative colitis (UC) are characterized by abdominal pain, diarrhea, blood in stools, weight loss, and fatigue. It presents in patients with varying severity from mild to severe depending on the inflammation. Detailed analysis and...
Autores principales: | Gara, Sirisha K, Guntipalli, Prathima, Marzban, Sima, Taqi, Muhammad, Aryal, Vinayak, Khan, Qurat ul ain, Shah, Shahtaj A, Akbariromani, Hanieh, Salinger, Darren, Diaz-Miret, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636694/ https://www.ncbi.nlm.nih.gov/pubmed/37954750 http://dx.doi.org/10.7759/cureus.46833 |
Ejemplares similares
-
The Prevalence of Anemia in Working Women
por: Shah, Shahtaj A, et al.
Publicado: (2023) -
Recurrence of Small Bowel Obstruction in Adults After Operative Management of Adhesive Small Bowel Obstruction: A Systematic Review
por: Victory Srinivasan, Nishok, et al.
Publicado: (2022) -
Safety and effectiveness of ustekinumab in Crohn's disease: Interim results of post‐marketing surveillance in Japan
por: Yokoyama, Seiji, et al.
Publicado: (2021) -
Increasing Rates of Infective Endocarditis in Patients with Inflammatory Bowel Disease
por: Shah-Khan, Sardar M, et al.
Publicado: (2020) -
Fecal Myeloperoxidase as a Biomarker for Inflammatory Bowel Disease
por: Hansberry, David R, et al.
Publicado: (2017)